Raymond James & Associates’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-2,343
Closed -$898K 2365
2015
Q3
$898K Buy
+2,343
New +$898K ﹤0.01% 1650